Lars F. Berglund, M.D., Ph.D.
Endocrinology, Diabetes, and Metabolism
- Interim Dean, UC Davis School of Medicine
- Associate Vice Chancellor for Research, UC Davis
- Professor of Medicine
- Emeritus Director, UC Davis Clinical and Translational Science Center
Dr. Berglund is currently Interim Dean of the UC Davis School of Medicine. He is also Associate Vice Chancellor for Research at UC Davis, and has led the UC Davis School of Medicine research enterprise since 2008.
Dr. Berglund served as the director of the UC Davis Clinical and Translational Science Center (CTSC) from its inception in 2006 until 2017, and has been very active in building an extensive collaborative framework. Previously he was the program director for the UC Davis GCRC, funded in 2004.
Dr. Berglund has served as PI for several NIH R01 grants and has worked in the area of lipoprotein metabolism, vascular disease, and HIV for more than 20 years. He has published more than 200 peer-reviewed publications and reviews, most of which have resulted from mechanistic, patient-oriented studies.
He is a member of the editorial boards of several journals, has chaired NIH and AHA study sections, and participated in several Endocrine Society guidelines committees as well as in the National Academies Steering Committee for the Decadal Survey on Biological and Physical Sciences in Space.
Dr. Berglund served as an inaugural co-chair of the CTSA Consortium's Oversight Committee, and was closely involved in strategic planning.
M.D., University of Uppsala, Uppsala, Sweden, 1981
Ph.D., University of Uppsala, Uppsala, Sweden, 1977
Internship: Huddinge University Hospital, Stockholm, Sweden 1981-1982
Karolinska Institute, Huddinge University Hospital, Stockholm, Sweden 1982-1984
Karolinska Institute, Huddinge University Hospital, Stockholm, Sweden 1984-1986
UC San Diego, San Diego CA 1977-1979
American Association for the Advancement of Science
American Association of Clinical Chemistry
American Heart Association, Council on Arteriosclerosis, Thrombosis and Vascular Biology
European Society of Clinical Investigation
Swedish Society of Clinical Chemistry
Select Recent Publications
Anuurad E, Byambaa E, Gungor Z, Zhang W, Pearson TA, Tracy RP, Kim K, Berglund L. Age as a modulator of inflammatory cardiovascular risk factors. Arteriosclerosis, Thrombosis and Vascular Biology (2011), 31:2151-2156.
Enkhmaa B, Anuurad E, Ozturk Z, Zhang W, Pearson TA, Berglund L. Differential associations of serum amyloid A and pentraxin-3 with allele-specific lipoprotein(a) levels in African Americans and Caucasians. Translational Research (2011), 158:92-98.
Stanhope KL, Griffen SC, Bremer AA, Schaefer EJ, Nakajima K, Schwarz JM, Beysen C, Hellerstein MK, Berglund L, Keim NL, Havel PJ. Metabolic responses to prolonged consumption of glucose- and fructose-sweetened beverages are not associated with postprandial or 24-hour glucose and insulin excursions. American Journal of Clinical Nutrition (2011), 94:112-119.
Enkhmaa B, Anuurad E, Pearson TA, Zhang W, Berglund L. Association of Lp-PLA2 activity with allele-specific Lp(a) levels in a bi-ethnic population. Atherosclerosis (2010), 211: 526-530.
Enkhmaa B, Anuurad E, Zhang Z, Pearson TA, Berglund L. Usefulness of apolipoprotein B/apolipoprotein A-I ratio to predict coronary artery disease independent of the metabolic syndrome in African Americans. American Journal of Cardiology (2010), 106: 1264-1269.
Kasim-Karakas S, Hyson D, Halsted C, van Loan M, Chedin E, Berglund L. Translational nutrition research at UC Davis ? The key role of the Clinical and Translational Science Center. Annals of the New York Academy of Science (2010), 1190; 179-183.
Ozturk Z, Enkhmaa B, Shachter NS, Berglund L, Anuurad E. Integrated role of two apoliprotein e polymorphisms on apolipoprotein B levels and coronary artery disease in a biethnic population. Metabolic Syndrome and Related Disorders (2010), 8: 531-538.
Reis SE, Berglund L, Bernard GR, Califf RM, FitzGerald GA, Johnson PC for the National CTSA consortium. A Roadmap for Re-engineering the National Clinical and Translational Research Enterprise: The National Clinical and Translational Science Award (CTSA) Consortium?s Strategic Plan. Academic Medicine (2010), 85: 463-469.
Anuurad E, Ozturk Z, Enkhmaa B, Pearson TA, Berglund L. Association of Lp-PLA2 with coronary artery disease: increased role of vascular inflammation in African Americans compared to Caucasians. Journal of Clinical Endocrinology and Metabolism (2010), 95: 2376-2383.
Boden-Albala B, Kargman DE, Lin IF, Paik MC, Sacco RL, Berglund L. Increased stroke risk and lipoprotein(a) in a multi-ethnic community: The Northern Manhattan Stroke Study. Cerebrovascular Disease (2010), 30: 237-243.
Califf RM, Berglund L for the Principal Investigators of the National Institute of Health Clinical and Translational Science Awards. Linking Scientific Discovery and Better Health for the Nation: The Maturation of Clinical and Translational Research in the United States. Academic Medicine (2010), 85: 457-462.